InsidersTradesSigma
Follow the RENOVARO BIOSCIENCES INC. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). The latest transaction was disclosed on 14 November 2023 (Attribution). Among the most active insiders: Miller Avram. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
RENOVARO BIOSCIENCES INC. is a company focused on developing biopharmaceutical solutions. It emphasizes research and innovation in the biosciences sector.